Relative Bioavailability of 2 Oral Formulations of Nintedanib

NCT02572752 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Nintedanib
DRUG: Nintedanib
DRUG: Nintedanib

Sponsor

Boehringer Ingelheim